Epigenetic Mechanisms in Allergic Diseases

Allergic diseases arise from complex interactions between genetic predisposition and environmental factors. Epigenetic mechanisms—stable but reversible biochemical modifications of DNA and chromatin—mediate these interactions by adjusting gene activity without altering the underlying DNA sequence. DNA methylation at cytosine–phosphate–guanine (CpG) sites, post-translational modifications of histone proteins (including acetylation and methylation) and non-coding RNAs collectively orchestrate the differentiation and function of immune cells. In the context of allergy, such mechanisms influence the balance between T-helper 1 and T-helper 2 subsets, skewing responses towards a pro-allergic Th2 phenotype. They also regulate epithelial barrier integrity in the airways, control the expression of cytokines and immunoglobulin E (IgE), and shape the memory of immune encounters. Environmental triggers—from airborne pollutants and microbial exposures to dietary components—can imprint epigenetic signatures at critical developmental windows, sometimes persisting into adulthood or across generations. Understanding these processes has profound implications for biomarker discovery, risk stratification and the development of targeted therapies aimed at reprogramming maladaptive immune responses.

Research from Nature Portfolio

Recent studies have applied high-resolution epigenome-wide analysis to identify disease-associated methylation patterns in nasal epithelial cells. Investigators collected nasal swabs from a paediatric cohort and quantified DNA methylation across the epigenome. Distinct sets of CpG sites and differentially methylated regions correlated with current asthma, allergic sensitisation and markers of airway inflammation such as exhaled nitric oxide. Many of the implicated loci mapped to genes involved in Th2 activation, eosinophil function and IgE regulation (for example IL4, IL13 and EPX). Moreover, epigenetic age acceleration in nasal cells was associated with allergic phenotypes, suggesting that environmental insults may advance cellular ageing in parallel with disease progression. These findings underscore the utility of non-invasive biosampling for early detection and mechanistic insights into allergic airway disease.

Epigenetic Mechanisms in Allergic Diseases publication trend

The graph below shows the total number of articles in epigenetic mechanisms in allergic diseases across all publications each year (not limited to Nature Index journals).

Technical terms

DNA methylation: Addition of a methyl group to cytosine residues, often at CpG sites, modulating gene expression.

Histone modification: Covalent alteration of histone proteins (e.g. methylation, acetylation) affecting chromatin structure and transcriptional activity.

Th2 differentiation: The process by which naïve CD4+ T cells develop into T-helper 2 cells, driving allergic inflammation.

Epigenome: The complete set of epigenetic marks across the genome of a cell or tissue.

CpG island: A genomic region rich in CpG dinucleotides, often located near gene promoters and subject to methylation control.

MicroRNA (miRNA): Small non-coding RNA molecules that post-transcriptionally regulate gene expression by targeting messenger RNAs.

References

1. The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback. Cell Communication and Signaling (2023).
2. Epigenome-wide meta-analysis of DNA methylation and childhood asthma. Journal of Allergy and Clinical Immunology (2018).
3. The nasal methylome as a biomarker of asthma and airway inflammation in children. Nature Communications (2019).
4. Epigenetic regulation of asthma and allergic disease. Allergy, Asthma & Clinical Immunology (2014).
5. Perinatal and Early-Life Nutrition, Epigenetics, and Allergy. Nutrients (2021).